News Conference News PCR London Valves 2024 Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP Michael O'Riordan December 05, 2024
News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2023 For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE Shelley Wood November 20, 2023
News Conference News PCR London Valves 2021 Good Results but Small Numbers With JenaValve Trilogy in Severe AR Michael O'Riordan November 26, 2021
News Conference News PCR London Valves 2021 ‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI Michael O'Riordan November 25, 2021
News Conference News PCR London Valves 2020 Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND Michael O'Riordan November 25, 2020
News Conference News PCR London Valves 2019 Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients Michael O'Riordan November 17, 2019
News Conference News PCR London Valves 2018 No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication Shelley Wood September 12, 2018
News Conference News PCR London Valves 2018 MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice Shelley Wood September 10, 2018
News Conference News PCR London Valves 2018 Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications Shelley Wood September 10, 2018
News Conference News PCR London Valves 2017 Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III Shelley Wood September 27, 2017